Notably, computational approaches such as BENEIN have demonstrated the potential of perturbing HDAC2 as master regulator to drive differentiation and revert cancer cells to normal-like states, reinforcing the significance of our findings on VPA’s role as an HDAC inhibitor [46]. The gene discussed is HDAC9; the disease is cancer.